Zitnik R J, Zhang J, Kashem M A, Kohno T, Lyons D E, Wright C D, Rosen E, Goldberg I, Hayday A C
Department of Internal Medicine, Yale University, New Haven, Connecticut 06520, USA.
Biochem Biophys Res Commun. 1997 Mar 27;232(3):687-97. doi: 10.1006/bbrc.1997.6358.
Human secretory leukocyte protease inhibitor (hSLPI) is produced by epithelial cells at mucosal surfaces, where it regulates both the neutrophil-mediated inflammation that characterizes inflammatory diseases, and pathogens themselves via both antiprotease and "defensin-like" activities. Additionally, hSLPI may regulate other processes such as cutaneous desquamation and placental invasiveness. To better understand the primary physiologic roles of SLPI, it will be important to establish a genetically tractable animal model, the most attractive candidate being the mouse. In this report, the cloning and characterization of murine (m) SLPI is described. mSLPI is encoded by a single copy gene, and appears structurally highly similar to hSLPI. At the same time, significant differences between mSLPI and hSLPI are presented, notably a difference in expression pattern, and a structural difference in the protease binding site that correlates with a difference in the spectrum of protease inhibiton. Such species-specific evolution of this protease inhibitor is notable given that species-specific structure-function differences have previously been reported for the alpha-1 antitrypsin family.
人分泌型白细胞蛋白酶抑制剂(hSLPI)由黏膜表面的上皮细胞产生,在这些部位,它通过抗蛋白酶和“防御素样”活性来调节以炎症性疾病为特征的中性粒细胞介导的炎症以及病原体本身。此外,hSLPI可能调节其他过程,如皮肤脱屑和胎盘侵袭性。为了更好地理解SLPI的主要生理作用,建立一种易于进行基因操作的动物模型非常重要,最具吸引力的候选动物是小鼠。在本报告中,描述了鼠源(m)SLPI的克隆和特性。mSLPI由单拷贝基因编码,在结构上似乎与hSLPI高度相似。同时,也呈现了mSLPI和hSLPI之间的显著差异,特别是表达模式的差异以及蛋白酶结合位点的结构差异(该差异与蛋白酶抑制谱的差异相关)。鉴于先前已报道α-1抗胰蛋白酶家族存在物种特异性的结构-功能差异,这种蛋白酶抑制剂的物种特异性进化值得关注。